TFF Group 

€16.78
39
-€0.03-0.18% Friday 10:41

Statistics

Day High
16.9
Day Low
16.78
52W High
46.81
52W Low
16.78
Volume
0
Avg. Volume
503
Mkt Cap
363.79M
P/E Ratio
0.16
Dividend Yield
2.98%
Dividend
0.5

Upcoming

Dividends

2.98%Dividend Yield
Nov 25
€0.50
Nov 24
€0.60
Nov 23
€0.60
Nov 22
€0.40
Nov 21
€0.35
10Y Growth
12.79%
5Y Growth
7.39%
3Y Growth
7.72%
1Y Growth
-16.67%

Earnings

7JanExpected
Q2 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

7.22%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
425.43MRevenue
30.71MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0IH4.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap370.89B
Merck & Co., Inc. is a global healthcare company that develops respiratory drugs, competing directly with TFF Pharmaceuticals' focus on developing and commercializing drug products based on its patented Thin Film Freezing technology for respiratory diseases.
GSK
GSK
Mkt Cap99.96B
GlaxoSmithKline plc is a multinational pharmaceutical company that produces a wide range of prescription medicines, vaccines, and consumer healthcare products, including treatments for respiratory conditions, making it a competitor to TFF Pharmaceuticals.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines in several therapeutic areas, including respiratory, making it a competitor to TFF.
Pfizer
PFE
Mkt Cap162.16B
Pfizer Inc. is a global pharmaceutical corporation that develops and manufactures drugs and vaccines for a wide range of medical disciplines, including respiratory diseases, competing with TFF Pharmaceuticals' product offerings.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.37B
Teva Pharmaceutical Industries Limited is a global pharmaceutical company that specializes in generic and specialty medicines, including treatments for respiratory conditions, making it a direct competitor to TFF Pharmaceuticals.
Novartis
NVS
Mkt Cap304.1B
Novartis AG is a global healthcare company that provides solutions to address the evolving needs of patients worldwide, including respiratory drugs, competing with TFF Pharmaceuticals in the respiratory treatment market.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie Inc. is a research-based biopharmaceutical company that develops and markets advanced therapies, including for respiratory diseases, making it a competitor to TFF Pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol-Myers Squibb Company is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases, including respiratory conditions, competing with TFF.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.22B
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that invents, develops, and commercializes medicines for the treatment of serious medical conditions, including respiratory diseases, making it a competitor to TFF Pharmaceuticals.
Sanofi
SNY
Mkt Cap106.01B
Sanofi is a global healthcare leader that researches, develops, and distributes therapeutic solutions focused on patients' needs, including respiratory treatments, making it a competitor to TFF Pharmaceuticals.

About

TFF Group engages in the manufacture of barrels and oak casks for wine and whisky. It operates through the following geographical segments: France, the United States, Europe, United Kingdom, Oceania and South Africa, and Other Areas. Its business lines include foresting, wine cooperage, wood products for oenology, stave milling, whisky and bourbon cooperage, cask making, and stainless-steel vat making. The company was founded by Joseph François in 1910 and is headquartered in Saint-Romain, France.
Show more...
CEO
Jérôme Jean Patrich François
Employees
1575
Country
France
ISIN
FR0013295789
WKN
000A2JSL8

Listings

0 Comments

Share your thoughts

FAQ

What is TFF Group stock price today?
The current price of 0IH4.LSE is €16.78 EUR — it has decreased by -0.18% in the past 24 hours. Watch TFF Group stock price performance more closely on the chart.
What is TFF Group stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on London Exchange exchange TFF Group stocks are traded under the ticker 0IH4.LSE.
Is TFF Group stock price growing?
0IH4.LSE stock has risen by +0.84% compared to the previous week, the month change is a +11.13% rise, over the last year TFF Group has showed a -9.05% decrease.
What is TFF Group market cap?
Today TFF Group has the market capitalization of 363.79M
What is TFF Group revenue for the last year?
TFF Group revenue for the last year amounts to 425.43M EUR.
What is TFF Group net income for the last year?
0IH4.LSE net income for the last year is 30.71M EUR.
Does TFF Group pay dividends?
Yes, 0IH4.LSE dividends are paid annual. The last dividend per share was 0.5 EUR. As of today, Dividend Yield (FWD)% is 2.98%.
How many employees does TFF Group have?
As of September 07, 2026, the company has 1,575 employees.
In which sector is TFF Group located?
TFF Group operates in the Lifestyle & Brands sector.
When did TFF Group complete a stock split?
TFF Group has not had any recent stock splits.
Where is TFF Group headquartered?
TFF Group is headquartered in Saint-Romain, France.